Loss-of-function mutations of DAP12 and TREM2 cause a recessively inherited disease PLOSL, manifesting in brain white matter. The genes of the DAP12-TREM2 signaling receptor are located on 19q13.12 and 6p21.1, to which linkage has been observed also in families affected by another immune-mediated demyelinating disease, MS. We have tested if allelic variation in DAP12 or TREM2 predisposes also to MS by monitoring carrier frequency of the Finnish PLOSL mutation in Finnish MS cases and by studying DAP12 and TREM2 in MS by linkage and association. To conclude, the DAP12-TREM2 complex unlikely has a role in genetic susceptibility of MS.
Introduction
The quite recently identified signalling receptor complex, formed by DAP12 (the gene also known as TYROBP, TYRO protein tyrosine kinase binding protein) and TREM2 (triggering receptor expressed on myeloid cells 2), is an important regulator of the innate immune system (Klesney-Tait et al., 2006) The DAP12 and TREM2 genes are expressed in various cell types of the myeloid lineage. The exact cellular processes as well as the ligands for TREM2 are still largely unrecognized.
Mutations of the DAP12 and TREM2 genes cause a recessively inherited rare disease of the bone and brain white matter called polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy (PLOSL) (Paloneva et al., 2000 (Paloneva et al., , 2002 . All Finnish PLOSL patients carry a 5.3 kb deletion of DAP12 (PLOSL Fin -deletion, Fig. 1) , and inactivating point mutations of TREM2 have been found in PLOSL patients of other populations (Paloneva et al., 2002) . The first symptoms of the disease are typically pain and fractures in wrists and ankles at early adulthood, followed by neuropsychiatric symptoms, dementia and premature death. The most prominent feature of PLOSL, as well as Dap12 deficient mice, is myelin loss in the central nervous system (CNS) (Paloneva et al., 2001; Kaifu et al., 2003; Nataf et al., 2005) . Both microglia, the resident immune cells of the CNS, and oligodendrocytes, myelin forming cells of the CNS, express DAP12 and TREM2 proteins (Kaifu et al., 2003; Roumier et al., 2004; Kiialainen et al., 2005; Takahashi et al., 2005) . Interestingly, TREM2 overexpression has been observed to protect mice from autoimmune demyelination; when experimental autoimmune encephalomyelitis (EAE) mice were injected with TREM2-transduced myeloid precursor cells, the clinical symptoms of the mice alleviated, and there was less axonal damage in the mice CNS (Takahashi et al., 2007) .
The DAP12 and TREM2 genes are located on chromosomes 19q13.12 and 6p21.1, respectively. Interestingly, linkage to these loci has been observed also in families affected by another, more common demyelinating disease, multiple sclerosis (MS) (Ebers et al., 1996; Haines et al., 1996; Sawcer et al., 1996; Kuokkanen et al., 1997; Haines et al., 2002; Reunanen et al., 2002; Haghighi et al., 2006) . MS is a Journal of Neuroimmunology 206 (2009) 86-90 
